Amyloid-peptide vaccinations reduce β-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice

B Liu, S Rasool, Z Yang, CG Glabe… - The American journal of …, 2009 - Elsevier
B Liu, S Rasool, Z Yang, CG Glabe, SS Schreiber, J Ge, Z Tan
The American journal of pathology, 2009Elsevier
Alzheimer's disease (AD) is pathologically characterized by accumulation of β-amyloid (Aβ)
protein deposits and/or neurofibrillary tangles in association with progressive cognitive
deficits. Although numerous studies have demonstrated a relationship between brain
pathology and AD progression, the Alzheimer's pathological hallmarks have not been found
in the AD retina. A recent report showed Aβ plaques in the retinas of APPswe/PS1ΔE9
transgenic mice. We now report the detection of Aβ plaques with increased retinal …
Alzheimer’s disease (AD) is pathologically characterized by accumulation of β-amyloid (Aβ) protein deposits and/or neurofibrillary tangles in association with progressive cognitive deficits. Although numerous studies have demonstrated a relationship between brain pathology and AD progression, the Alzheimer’s pathological hallmarks have not been found in the AD retina. A recent report showed Aβ plaques in the retinas of APPswe/PS1ΔE9 transgenic mice. We now report the detection of Aβ plaques with increased retinal microvascular deposition of Aβ and neuroinflammation in Tg2576 mouse retinas. The majority of Aβ-immunoreactive plaques were detected from the ganglion cell layer to the inner plexiform layer, and some plaques were observed in the outer nuclear layer, photoreceptor outer segment, and optic nerve. Hyperphosphorylated tau was labeled in the corresponding areas of the Aβ plaques in adjacent sections. Although Aβ vaccinations reduced retinal Aβ deposits, there was a marked increase in retinal microvascular Aβ deposition as well as local neuroinflammation manifested by microglial infiltration and astrogliosis linked with disruption of the retinal organization. These results provide evidence to support further investigation of the use of retinal imaging to diagnose AD and to monitor disease activity.
Elsevier